Delivery Order SPE2DB20D3103-SPE2DB25FP9F4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,141.96 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal spray on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation used for acute seizure management, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.89 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizure episodes in patients with epilepsy, representing a critical specialty...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded on August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute repetitive seizure clusters in epilepsy...
- The Defense Logistics Agency awarded a delivery order valued at $6,761.00 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a FDA-approved nasal spray formulation of diazepam used for acute seizure management, making this procurement part of the...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.29 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used in emergency seizure management, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, valued at $13,527.84 on August 12, 2025, with completion expected by August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute seizure management, reflecting the Defense Logistics Agency's medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used to treat acute seizure clusters in patients with epilepsy, representing a specialized pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,301.07 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, effective July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute seizure management, reflecting the pharmaceutical supply needs of...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.44 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed price contract, awarded on July 25, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, valued at $1,160.56 with a firm fixed price arrangement. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9F4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,536.19 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Valtoco 10 mg nasal sprays. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a prescription nasal spray used for acute seizure management in patients with epilepsy and represents part of AmerisourceBergen's broader pharmaceutical supply portfolio to federal medical systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for Defense Health Agency and military healthcare systems, supplying specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract demonstrates the company's continued role as a primary supplier within the DLA Medical Supply Chain supporting global military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/18/25 |